Structured content authoring is transforming drug approvals processes

Structured content authoring is transforming drug approvals processes

Guest post by fme partner Maarten van Vulpen, Customer Success Manager, Fonto

In this dynamic, digital era – and in the context of expedited drug approvals processes, post pandemic – continued reliance on static, single-use Word documents to capture and publish or exchange critical information with Regulatory agencies makes no sense. It is hampering productivity, efficiency, compliance and visibility. Fortunately, there is a better way. Structured content authoring is already transforming drug approvals processes in Life Sciences.

In other industries, including the precision engineering and manufacturing-based automotive and aerospace industries, the automatic re-use of approved, structured content assets (fragments of approved text) is well established. Automatically generating onward documentation from a single source of approved content truth is the key to accuracy, reliability, and traceability as well as process efficiency.

And now Life Sciences, as it undergoes digital transformation, is beginning to recognize and reap equivalent benefits of structured content authoring (SCA) and automated content re-use, with a powerful impact on internal process efficiency.

There’s a practical imperative to this, too. In a bid to accelerate the approval of important drugs and make their own processes more efficient, health agencies are become more digital and dynamic in their information management and exchanges – an expectation they are passing on to drug manufacturers and license holders.

Yet, as long as these companies persist with Word/Excel/PDF based information and content management, they will only be creating more work for themselves in their efforts to keep up with those changing demands.

Driving new value from existing information with structured content

Pharma companies are already rich in regulated product information. The challenge is that much of this exists within single-purpose documents, dotted around different systems across the organization. This means that for each new purpose, teams have to go through protracted and laborious processes to locate, piece together, and seek approval for each new document use case – whether they’re generating a study report, submitting a new marketing authorization application, registering a product change, or updating labelling.

Structured content authoring tools like Fonto Editor strike right at the heart of this situation, transforming the way pharma subject matter experts (eg Clinical Trials, Regulatory, Quality or Safety teams) collate, publish, and manage vital drug information right across the product development, registration, and marketing lifecycle. Crucially, they are able to do this without having to brief out the content creation to technical writers, then check and approve their output. That’s because the SCA solution is intuitive for users, offering them a very familiar, Word-like experience, while building from content dynamic, reusable digital content assets.

Although there isn’t yet a single, agreed standard or schema for how documents should be constructed across Life Sciences globally, this will come in time and companies will be able to adapt to this relatively easily. That’s as long as they have got to grips with structured content authoring – and the immense scope for more reliable, efficient, and repeatable use of regulated information across a wide range of applications.

Transformation from the core

An obvious place to start in the adoption of SCA in pharma is the core data sheet, a key document representing the pharmaceutical company’s position on – and the definitive, correct, and current truth about – a product.

Once the core data sheet’s contents have been structured and stored as a series of digital content fragments, they can be flowed into a whole host of other documents including submission applications, reports, labels, and clinician/patient information, without risk of manual error – or the need for new rounds of internal content checks.

One of the top 5 pharma companies globally has already seen a 15% increase in productivity in processes linked to drug approvals, since adopting Fonto Editor to more automatically generate content that sails through internal checks.

By combining both Fonto and fme’s knowledge and experience with advanced ECM solutions, pharma professionals get several benefits. First, Fonto shields them from having to understand the ins and outs of XML formatting – a substantial win and time saver. Second, teams from across the drug lifecycle can gain seamless access to SCA capabilities from within their existing regulatory information management (RIM) platforms as a natural extension of their everyday work.

fme & Fonto: a formidable SCA partnership in Life Sciences

fme and Fonto share a strong pedigree in transforming Life Sciences content and data management, working together to integrate and embed SCA within companies’ Veeva, OpenText Documentum, or Generis CARA, or other systems. This means that relevant functional teams can shift to structured content management and authoring without having to learn to use new, separate tools.

For more details on structured content, Fonto has presented, and continues to present courses on the potential for structured content in Life Sciences via the Drug Information Association (DIA) – here’s a link to a recent session.

 

 

As the Life Sciences industry grows more serious about digital process transformation, fme has been highlighting the potential of SCA, too. In this post from fme’s Manuela Bernhardt, she explain that “Data is the heart of the business, whereas documents are the ‘packaging’ to create context”.

 

 

A dynamic pharma future needs structure

Over time, the opportunities for transforming content management processes through re-use of approved digital assets with at least some degree of automation will only grow. The regulators, as well as competitive market pressures, will demand it; meanwhile technology vendors like Veeva will continue to pave the way for powerful content re-use, as long as this is planned properly (for instance, with the support of RIM vendors like Veeva delivered through specialist Life Sciences partners like fme and Fonto).

To find out more about the potential for structured content authoring and management in your own organization, download this data sheet covering fme and Fonto offerings.

Click here to learn more about Fonto’s partnership with fme.

Or contact us to start the discussion today!

About the author

Maarten van Vulpen is customer success manager at Fonto, the leading solution in structured content authoring. This role gives Maarten the opportunity to discuss structured content authoring, its advantages and innovation with customers and potential customers from multiple industries, including life sciences. 

Join fme in Boston at the Veeva Summit: R&D and Quality

Join fme in Boston at the Veeva Summit: R&D and Quality

fme has been selected as a Gold Sponsor for the Veeva Summit: R&D and Quality for Boston this September, and we are looking forward to sharing our experience and strategies with the Veeva community. We enjoyed June’s European summit in Madrid, and are honored to be recognized in an elite group of certified partners invited to participate in the North American event.

We’d love for you to join us to explore how to leverage the power of the Veeva platform to achieve your business goals.

Join fme at the Veeva Summit!

fme specializes in the end-to-end implementation, integration, and support of the Veeva platform. At the summit our team of experts will be answering questions, discussing our capabilities, and proving how our partnership can guide organizations to new heights of efficiency and productivity. We will also be highlighting our newest offerings that deliver exceptional benefit to our Veeva clients:

  • fme PlatformAssist™ – A comprehensive set of modular building blocks that provide you with the unique end-to-end services needed for carefree post go-live management of your Veeva platform.
  • dqMan for Veeva Vault – Modeled after our popular dqMan for Documentum, our new version is focused on the specific requirements of Veeva clients, eliminating time-consuming and repetitive tasks and making admin and data management easy.
    If you are attending the summit, contact us and let’s set up a time to meet so you can get the most value from the summit.

If you are attending the summit, contact us and let’s set up a time to meet so you can get the most value while we’re there together.

Contact us to learn more

fme delivers the end-to-end knowledge and support you need to maximize the value of the Veeva platform. We’d love the opportunity to share our experience on how to best configure, utilize, and support Veeva for the unique challenges of your organization.

Contact us to schedule a personalized presentation aligned with your unique challenges. To schedule a discovery meeting with fme’s Veeva experts, reach out to our Global Sales Director René Rosenberg at r.rosenberg@fme-us.com.

Key topics for Life Science companies considering SaaS solutions

Key topics for Life Science companies considering SaaS solutions

Even in highly-regulated industries like Life Sciences, accessing key systems via the cloud, on a software-as-a-service (SaaS) basis, is rapidly becoming the default as consumer-based habits around everyday application use extend to the workplace. But what are the key considerations, and how do you choose a provider? Here are 5 common topics to focus on.

Businesses used to view cloud-based software and data hosting, along with subscription-based delivery (e.g., Software-as-a-Service, or SaaS, delivery models) with considerable caution. Concerns about risk to business continuity in the case of network or data center downtime; fears of supplier lock-in or security breaches; and questions about long-term cost of ownership seemed to undermine the promise of simplified IT management; improved speed of deployment; and more flexible access to systems and data beyond the office.
Today, cloud and SaaS-based system delivery is not only proven; it is fast becoming the norm. And this extends to strictly-regulated industries too, including Life Sciences.

The technology has matured considerably; networks/connections and backup provision are altogether more robust; service provider offerings have become incredibly sophisticated to appeal to corporate buyers; and the pace of technology advancement has accelerated to the point that the alternative – buying software and running and managing it on premise – no longer makes business sense in the majority of use cases.

As digital-native generations enter the workforce, and as employees generally become familiar and comfortable with using the cloud to store photos and documents in their personal lives via their smartphones and other devices, the appetite for cloud-based application access is growing too. The perception of risk associated with externally-hosted applications has greatly decreased, especially as built-in cloud security becomes increasingly sophisticated.

Despite users’ increasing comfort level when it comes to relying on hosted solutions in their day-to-day lives, there are some important considerations when deciding to move a business process to a cloud/SaaS platform.

Below are some of the considerations for business functions when making decisions related to cloud-based SaaS deployment:

1. Integration options

Although there is a general belief that cloud-based software makes it easier to connect and exchange data between applications, this isn’t a given. While it is possible to connect platforms through application programming interface (API) calls (a message sent to a server asking for information), those applications may not have an intensive library of calls, depending on the level of development investment the supplier is willing to make. Additionally, there can be barriers to implementing integrations like sharing security protocols or opening firewall ports where multiple suppliers are required to coordinate/cooperate with each other to enable the requested functionality.

2. Validation

In regulated industries like Life Sciences, software must be shown to be reliable in delivering what’s expected and to support patient safety, product quality, and data integrity. That means conducting risk-based testing and compiling as well as maintaining documentation proving that the software functions as designed and required.

In a cloud-deployed SaaS context, many software providers will include access to their validation package, even if there is a modest associated fee to access the associated scripts and documentation. In this context, the challenge of cloud-SaaS is the software functionality is subject to regular updates throughout the year, with customers largely at their mercy. Each update will require an impact assessment to identify any changes that will need to be made to existing configurations, as well as understanding new configurations that the business may wish to implement. Along with these changes, some level of validation will be needed, which requires involvement from internal teams.

The advice here is to:

  • Refrain from too much customization. Stay close to the out-of-the-box functionality, wherever possible. Choosing the best fit initially will help considerably here.
  • Check out the validation provisions ahead of time to avoid resourcing issues later.

It’s worth looking into associated documentation and training, too, as this can help users get up and running quickly and confidently using the new software. Best-case scenarios can be within a couple of months compared to 12-18 months for an on-premise deployment.

3. The risk appetite of the relevant business function

With so much security and trust built into cloud/SaaS services now, decisions about whether to embrace externally-hosted/subscription-based software access comes down largely to the risk appetite of the given business function. Often, the advantages substantially outweigh any negatives–reduced reliance on internal IT help and support, and faster access to the latest technology features are among the bigger pluses of choosing the cloud/SaaS route. Again, it is vital to perform an assessment of the preferred SaaS provider. It’s also a good idea to check whether your peers are among their customers, as this will provide useful clues to the supplier’s credentials in your sector.

4. Licensing/pricing and scalability models

One of the great appeals of accessing software through a SaaS model is the ability to spread costs, and to scale capacity with the needs of the business. But it’s important to examine the overall cost of ownership over time. Be sure to check the terms and conditions around price increases and clauses related to scaled demand. Many SaaS models offer tiered pricing depending on the role, where a read-only account has a different cost compared to an account that can create and edit content. So be sure to plan for the number of users you will need as well as the specific roles each user would require.

5. Ongoing support

This is something we’ll cover in a separate blog, but it’s important to at least mention here the importance of assessing what is provided for in the way of post ‘go-live’ support. Also, what that might look like in reality if you actually have to use it (something you can’t know in advance).
Direct vendor support might be fairly rudimentary, but there may be a certified partner that can bridge any gaps and provide a more tailored service that fulfils the business’s requirements.

Learn more

To find out about fme’s comprehensive SaaS consulting, implementation and support services, including our platform-assist offering, please contact us and and we’ll schedule a time to discuss your specific requirements.

Whitepaper: Essential Steps to a Successful Data Migration

Whitepaper: Essential Steps to a Successful Data Migration

As companies undergo significant changes and upgrade their core systems, ensuring the quality and usability of the data being migrated is paramount to unlocking the full potential of new technologies. We are excited to share practical tips and insights gained from decades of project experience in complex data migrations to help you achieve a smooth and successful transition. Read our Essential Steps to a Successful Data Migration whitepaper to gain invaluable knowledge to support your digital transformation journey.

In this paper we cover:

  • Realistic Scope of Data Migrations: One of the most common barriers to a successful data migration is failure to realistically and independently plan the time required to classify, migrate, and verify the data.
  • Effective Migration Project Phases: It is critical to break the data migration into logical phases that are aligned with the wider digital transformation initiative.
  • The Importance of Validation: Validating the migration is essential to ensure data can be recalled and relied upon as part of business processes, and requirements should be agreed upon from the outset.

Don’t wait – get this paper before your project starts!

In the rapidly evolving digital landscape, it is critical to get the most ROI from your technology investment. This paper outlines invaluable steps to ensure you achieve the full potential of your digital transformation by providing insights and practical strategies to navigate the complexities of data migration. Gain access to expert knowledge that will empower your organization to scope your project properly, craft an effective migration strategy, and plan for critical data validation after your migration. Download our whitepaper today and ensure the first step to unlocking the full potential of your digital transformation journey is successful.

Challenges of managing and maintaining on-premise and cloud business applications

Challenges of managing and maintaining on-premise and cloud business applications

In today’s fast-paced digital world, businesses need to stay on top of their technology game. However, managing business applications can be a challenging task, especially for small and medium-sized businesses (SMBs) that have limited resources to maintain an in-house IT team for specialized business platforms. Below are some of the challenges, and how fme TechOps Support Services provides the solution.

Challenge 1: Aligning business needs with vendor releases

With the introduction of cloud-native or SaaS applications, companies struggle to stay on top of vendor releases and effectively manage application updates that are pushed automatically. If you are “lucky” you have some flexibility to schedule based on your internal timelines, but that’s not always the case. However, it happens, someone needs to assess the impact of the updates to the business functionality and process, and someone needs to complete the validation. Unfortunately, it is not uncommon for team availability, experience, and knowledge to not be in sync with vendor schedules. Teams facing a large amount of other “Priority 1” items risk overlooking important considerations for the rollout of the new release or are unable to realize its full potential as they juggle and prioritize critical deadlines. We’ve seen many over-burdened businesses miss out on important improvements.

This is where external support like fme’s TechOps Support Services can help. Our team is experienced in reviewing and assessing releases for impact, and are able to scale up to implement the update as the releases are published. We identify the musts and maybes (in Veeva lingo – auto-on and auto-off) and hold them side-by-side to business functionalities to clarify impact to current process and functionalities. We then highlight valuable improvements that can provide clear benefits. Next, we help with any resulting configuration and (validation) documentation updates and make sure the release update process runs smoothly and turns into a “non-event”.

Challenge 2: Keeping pace with your evolving business

While being buried in day-to-day business and vendor release management it is easy to forget about evolving business needs. As a business uses their business applications every day, it is expected that they will find areas for improvement and enhancement. Whether there are flows and pages that can be streamlined to the actual use, or additional documents and processes that should be included, your team will make improvement requests which will need to be properly captured and followed up on. When we’ve started working with many clients, we could see the capturing process working, but a majority of improvement requests get eternally deprioritized or forgotten over time. This leads to frustrations between IT and the business team.

fme’s TechOps Support Services addresses this gap and the management of the backlog of requests. We can assess each request, identify the technical impact and necessary implementation steps and efforts, prioritize them based on business input, and align them to releases on the business roadmap. This can all then be coordinated with upcoming vendor releases and other platform maintenance activities. From technical solution design, to implementation, rollout and (validation) documentation, we make sure that each business application release is treated as a mini project and gets proper attention. With this organized approach, the business benefits from the continuous improvement of the application, and the team is able to work more effectively and efficiently.

Challenge 3: Day-to-day business issues

Besides planned release and application updates happening multiple times per year, every company has unplanned IT application issues and needs every day. Some are caused by the system, and a few may or may not be caused by the users. Either way, they still need to be corrected so the team can get back to doing their jobs to make the company successful. In most SMB firms, the IT team supports a wide range of technology across multiple integration points. The team has to juggle conflicting priorities as their focus shifts from business applications to other important tasks on their plate. In a perfect world, everyone would be trained on every solution and understand how they all work together. The reality is somewhat different. We frequently work with very talented teams where:

  • Older solutions on legacy platforms are maintained by long-time staff who carry the major knowledge of the application. Newer staff aren’t as familiar with the details or unique configurations.
  • Newer solutions have been added that the entire team is not sufficiently familiar with yet. Many companies opt for ‘train-the-trainer’ onboarding programs, but then struggle to make time to disseminate the knowledge to the full team.
  • Integration points between applications require additional knowledge to ensure they work together, and not all workflows, configurations and integrations are documented in line with ‘the way things actually work.’
  • Important team members have left the organization, leaving a substantial gap in institutional knowledge.

Neither SMB nor enterprise firms have the IT budget they need to have enough experts on-staff to eliminate all of these challenges. These issues inevitably combine to create frustrating situations where resolutions are delayed because immediate challenges fall outside the “sweet spot” of the available support team members.

In a growing business with modern solutions, these types of delays happen more frequently than they need to. An essential question to ask is “Is the quality of your support services provided by your internal team living up to yours and the business’ expectations?” It should not be asked critically, but with the goal of ensuring that the business needs of the company are being met effectively and economically. You should be able to leverage your technology to help achieve your business goals, not be crippled by it as you struggle to maintain and increase the ROI of your investment.

With many of our clients, fme helps fill the knowledge gap with our TechOps Support Services. We provide an experienced team of experts to address their day-to-day business challenges in an efficient process that scales as needs require. Many of our clients take advantage of this service after new solutions go live and they are still in the onboarding cycle. This allows the team to complete their training in the new platform while having solution support available to solve more complex challenges.

From our experience, bringing in flexible, external specialist support allows for better control of costs and support outcomes, and allows internal teams to refocus on critical tasks beyond the standard support issues, direct business questions, and required daily administrative tasks. Our global team is trained across leading business application platforms including OpenText Documentum, Generis CARA and Veeva Vault.

fme TechOps Support Services is scalable and agile

Every company goes through the above challenges, and must face them in a way that aligns with their business goals and limitations. Tailoring our services to our clients’ needs is our top priority. Our offerings are modular, and components such as release and demand management can be added or removed as needed. We understand that needs might vary between platforms and clients, but also might fluctuate within the course of a year depending on vendor releases or critical business activities. Together with our clients we keep a close eye on current versus upcoming needs, and scale our team size up and down as needed to accommodate the specific skillsets and resource needs expected for upcoming activities. Clients appreciate our agility and flexibility, our long-term client relationships are proof of that.

Learn more about fme TechOps Support Services

Do you have full control over the post-implementation activities for your business applications? Is the business happy and satisfied with the support that they are receiving? Not just for immediate issues, but also for processing releases and backlog items? fme’s TechOps Support Services can help. Our team will be happy to review your current processes, platforms and challenges with you and identify potential areas where we can help you work more effectively, efficiently and economically.

Contact us today to learn more about fme’s TechOps Support Services. It’s a cost-effective solution to manage modern IT challenges with the business factor in mind.

Preparing for Migration: Critical steps to know

Preparing for Migration: Critical steps to know

In a previous article “Migration strategy and the path to operational resilience”, we examined the relationship between data migration and regulatory compliance, and the importance for enterprises to create a clear plan for initiating a data migration. Today, we will look at how migration is never one size fits all, and how each company’s migration journey will be different, requiring strategic approaches linked to the complexity of the unique data. There are several key steps to ensure migration initiatives are as streamlined as possible.

  • Understand the project scope: Assessing the quality of data, requirements, and complexity of data will help you set the right migration strategy.
  • Set realistic timelines: The assessment phase will help create an achievable migration plan that includes an ability to clearly measure progress.
  • Define the migration rules with the experts: Allow the migration expert to come out with the migration order and the rules for you to confirm.
  • Validate the migration: Set the testing strategy during the assessment phase. Conduct preliminary testing during the building phase and confirm with the business that all use cases were considered when preparing the test scripts.
  • The final migration strategy: The migration strategy dictates how the migration will be performed, on a one time basis or incrementally, and how to shut down and dispose of old legacy systems.
  • Sanity checks in production: Once the migration is complete, a sanity check on the agreeable amount of migration data should be initiated to prove that the migration is performed in accordance with the validation phase.

Define the scope of the project

Scoping a migration project involves defining the parameters, requirements, and goals of the project, and developing a clear plan and timeline for the migration. It’s also important to define the limits of the project and identify what won’t be included in the current phase.

For example, in the pharma industry, the implementation of the IDMP (Identification of Medicinal Products) standards requires updates, changes, and possibly even the roll-out of a new information system, but this type of agile modus operandi doesn’t always align with the pharma industry’s historically siloed way of working. Nearly every team in the drug development lifecycle – safety, clinical, regulatory, and research and development – can use different, disconnected systems that might not even integrate (e.g. Submission management, RIM, Master data management, Pharmacovigilance, Document management system etc.). Additionally, they are encouraged by the IDMP implementation to apply a single unified, holistic platform that removes silos connecting data and people.

When a decision on the implementation of a new solution and migration is made, it is important to set a clear scope and goal for the whole project. In the context of the implementation of regulatory solutions in the pharma industry, this can be a big deal for the company and the comprehensive assessment of the project is of paramount importance.

Getting started: Plan a data assessment

Before commencing, it is critical to have a clear overview of the project scope, data, and information to ensure efficient planning and execution. Data migration projects in the life science space are often complex, time-consuming and in most cases involve multiple systems and different technology. A clear and comprehensive assessment phase is key to avoiding exceeding predetermined budgets, implementation delays or undercutting business processes. The assessment phase is primarily used to review and assess the data in the existing systems and identify any potential issues and risks that might occur during the project. The purpose of this phase is not to carry out any migration activities, but to benchmark the scope, set recommendations, strategy and ensure visibility for the client. At this juncture, the client should have already known the migration requirements and the expectations for the migration. As a result of the assessment, a decision can be made to go further with the major project after the plan is clear or whether a POC (Proof of Concept e.g. with the migration-center PoC Package) should be performed to assess some more complex data of the migration (e.g. Migration of the drug registration history).

Choosing the right migration approach

Once a thorough data assessment has been carried out, the next step is to decide on the right migration approach. Every company’s data is unique, and the appropriate migration strategy will depend entirely on the quality, value, and complexity of the data. For example, sensitive regulatory data should be handled with particular care. Moving ahead without proper planning will ultimately cause more work in a later phase, and possibly undermine a project’s success. We often recommend businesses to migrate registrations of important products separately and the rest after the go-live, using the same migration rules. This decision can be made if a high volume of data should be enriched, and the business cannot provide them on time. Another important consideration is whether to migrate everything at once – a Big Bang migration – which requires considerable time and resources to complete. Alternatively, businesses can carry out the migration incrementally and transfer data in phases – this is a rolling migration. A big bang can be more straightforward, but a problem with this approach is that no additions or changes can happen during this time, as all data processes are paused during the migration process. An incremental approach doesn’t require as much downtime but can bring more complexity as the source and the target system are run in parallel, eliminating downtime.

 Aligning project & migration timelines

Knowing when to initiate the migration is pivotal. Ideally, the migration should take place in parallel with the solution implementation process, and the development of the migration rules should follow the implementation cycles. For example, when the solution implementation of master data is locked, the definition and development of the migration master data can start and eventually be migrated. After each cycle, the business should confirm the migrated data in the target system and if all the requirements were fulfilled. This approach tells us that we need to understand the whole concept of the project, including the implementation of the solution when building the plan. Otherwise, it is impossible to set all cycles in a logical order and set the right priorities. It is essential that the data migration is carried out in tandem with domain experts that have the technological know-how and strategic acumen to deliver.

Consider a Proof of Concept data migration

Rigorous planning and assessment are critical to the success of any data migration project, and in some instances, a proof of concept (POC) is highly advisable. A POC data migration is essentially a trial run of a larger data migration project, geared towards testing the feasibility of migrating data from one system to another. The purpose of the POC is to demonstrate the viability of the data migration project and to identify any potential issues or challenges that may arise during the actual migration process. When a company is approaching a large-scale data migration, or a high-risk migration involving sensitive or mission-critical business data, a POC can provide significant value.

For a successful POC, it is important that the business provides rich sample data so that the migration team can test and verify the exact processes that will be used in the full migration.  Before running the POC, businesses should:

  • Review sample data sets and consider all use cases
  • Confirm the result of the migration fulfills the requirements
  • Examine and define any gaps and how to fill them
  • Define what work is required if they need to enrich their data

By its very nature, migrating data can be a complex and protracted process, and if not thought out fully in advance, can lead to significant data loss and system downtime unless conducted with a professional migration software. In our next blog, we will highlight the key success factors and best practices for optimized migration.

Contact us to start your migration right

Whatever the reason for the data migration, the goal of all stakeholders is to provide a solution to the business in order to improve business performance and ensure competitive advantage. To achieve this, they should give more attention to data migration and be smarter in the assessment, planning, and migrating data with experts that have experience and knows the business in the life science industry.

fme has been guiding global pharmaceutical and manufacturing firms through their complex migration journeys for over 20 years. We’ve even developed our own proprietary tool migration-center to enable seamless migrations with minimal downtime. Contact us to discuss your challenges and start your journey on the right path.